Key Takeaways
- Margin surge, but management won't call it permanent: EBITDA margins jumped on CRGO scarcity and a deliberate inventory-holding tactic, yet management explicitly refuses to commit to sustaining these levels, calling them "exceptional."
- Capacity is the bottleneck, not demand: The plant is running at over 90% utilization, capping H1 revenue growth at just 2% despite a multi-year demand super-cycle. The growth story hinges entirely on the new facility coming online.
- Expansion delayed, but the path is now concrete: Trial runs at the new plant are now set for March 2025, a 45-60 day delay from the original plan due to floods and approvals. Management targets a doubling of capacity to 24,000 metric tons next fiscal year.
- The balance sheet is absorbing growth's upfront cost: Working capital has swelled as the company stockpiles scarce CRGO to avoid customer disruption, pushing up inventory and receivables. Management insists this is strategic and that the company remains net debt free.
- What to watch next quarter: Whether the March trial run stays on schedule, the trajectory of CRGO prices as Chinese supply remains locked out, and any sign that the current "exceptional" margins are beginning to normalize.
The Margin Spike: Windfall or New Floor?
- Scarcity drove the surge: The government's cancellation of BIS licenses for Chinese mills in late March choked off a key supply source, causing CRGO prices to rise steadily (4%, 5%, 7%) and allowing the company to expand margins.
- A deliberate inventory play amplified the gain: Management held back sales in April and May when prices were rising, then sold the majority of material from June through September, capturing the price increase on inventory booked at older, lower costs.
- The floor is last year's low, not this year's high: Management stated the minimum EBITDA margin produced in March 2024 is the base, and margins will never go below that level. The current elevated margins are described as "exceptional."
- Normalization trigger is clear: If CRGO availability increases, margins may come down 2%-3% to the original sustainable level. That sustainable margin is protected by strong demand; margins only fall when demand collapses and supply floods the market.
- No commitment to the peak: When asked if margins could rise to 15% or higher, management declined to forecast a maximum, stating it "purely depends on the supply and demand."
Patel: "If the market remains in similar way, yes we can maintain that. But how market will react after 6 months or 10 months or a year, we don't know. So, committing that we will definitely maintain this, is not the right thing."
Capacity Expansion: The Real Growth Engine
- The current plant is maxed out: Operating at over 90% capacity utilization, the existing facility cannot take additional orders despite high demand, limiting H1 revenue growth to just 2%.
- New plant timeline has slipped but is now firm: Construction started in May-June and was delayed 45-60 days by heavy rains and flooding in Baroda, plus the time needed for multiple product approvals. Machinery is ordered, with inspection in December, shipping by December end, commissioning in January-February, and trial runs in March.
- Capacity will double, then triple: The expansion adds 2,000 metric tons of total capacity. Management targets 1,000 metric tons per month by March 2026 (doubling current output to 24,000 metric tons annually) and another 1,000 metric tons by March 2027 (reaching 36,000 metric tons). No additional CAPEX is needed for this ramp.
- Flexibility is built in: The company can accelerate the ramp-up if the market is strong or slow it down if conditions weaken, giving it an operational hedge against demand uncertainty.
- Revenue will follow capacity: Management revised its FY25 topline target to nearly ₹360-₹370 crore (from ₹400-₹450 crore) due to the capacity constraint, but guided for ₹650-₹700 crore in FY26 as the new plant comes online.
Patel: "While I'm trying to speed up the setup, we are not overly rushing at cost of any compromise."
Demand Environment: A Multi-Year Tailwind
- Transformer makers are booked solid: In India, order books cover 1-1.5 years of capacity; internationally, particularly in the US, companies are booked for the next 3-4 years. This pipeline provides deep visibility into demand for CRGO laminations.
- The super-cycle has structural drivers: Demand is expected to remain strong and increase for the next 5-7 years, fueled by green energy build-out, transmission network upgrades, and solar and wind projects.
- Customer financial health is strong: Unlike 5-7 years ago, transformer companies now have good cash flow and do not sell much on credit. Management sees no financial stress among its prominent customer base.
- Efficiency can squeeze out a little more: The existing plant can still deliver 10%-15% revenue growth this year through Kaizen-driven efficiency improvements, even before the new capacity arrives.
Patel: "If you will see the transformer industry result in order booking and everything, you will understand that the present order booking is more or less all the transformer companies' book for 1-1.5 year of their capacity. If you go internationally, US and all those market, transformers companies are booked for next three to four years."
Supply Chain: Stockpiling for Security
- CRGO scarcity forced a strategic inventory build: To ensure customers do not suffer and growth does not halt, the company is keeping more stock of all CRGO grades. Inventory has risen from one month's turnover to two months' turnover.
- Supplier base is diversifying: Orders have been placed with a Polish mill, a Brazilian mill (Go Steel/Arcelor Mittal), and Japanese players for amorphous material, reducing reliance on any single source.
- Chinese supply remains locked out: The government cancelled BIS licenses for Chinese mills in late March, and none have been restored. Even if Chinese mills restart, management notes they are "smart" and price BIS-approved material at a premium to non-BIS material.
- Working capital is the price of security: The inventory build and a policy of not discounting LC-based sales (to avoid interest costs) have increased both inventory and trade receivables. Management states most payments are against LCs and are realizable, and the company remains net debt free.
- Short-term debt is tactical, not structural: Buyer's credit was taken for approximately 30 days to manage dollar pricing when the dollar was high, not as a permanent financing need.
Patel: "That license was cancelled in the March end only. And yes, the material from China is not coming right now. And none of the license for Chinese mill has been restored."
Product Portfolio: Radiators and Nanocrystalline Cores
- Two new product lines are being added: The company is expanding into transformer radiators and nanocrystalline cores, both to be manufactured at the new facility.
- Radiators offer a margin kicker: Radiator margins are approximately 3%-4% higher than CRGO margins, and management targets a 10%-15% revenue contribution from this segment over time. The market is fragmented with many small unorganized players.
- Nanocrystalline is a high-margin niche: The company already operates Nano Cryst Transcore in Manesar with ₹6-₹7 crore in turnover. It is a highly technical product with very good margins, but the ramp-up will be slow: management plans to reach only 10 or 12 cores in the first year due to the long process and many product variants. A 5%-6% revenue contribution is targeted after 3-4 years.
- Amorphous margins are in line with CRGO: The amorphous product line, supported by new Japanese supplier relationships, carries margins similar to the core CRGO business.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| New plant trial production | Trial runs to begin | March 2025 |
| Capacity doubling | Reach 24,000 metric tons annually (from 12,000) | FY March 2026 |
| Capacity tripling | Reach 36,000 metric tons annually | By March 2027 |
| FY25 topline | Nearly ₹360-₹370 crore | FY25 |
| FY26 topline | Around ₹650-₹700 crore | FY26 |
| Margin floor | EBITDA margin will not fall below the March 2024 base level | Ongoing |
| Margin normalization trigger | If CRGO availability increases, margins may fall 2%-3% to sustainable level | Conditional on supply |
| Working capital self-sufficiency | Up to ₹600 crore in sales, no additional debt needed beyond internal cash flow | Until March 2026 |
| Nanocrystalline ramp | 10-12 cores maximum in first year | First year of production |
| PGCIL approval for new facility | Approval process to start once facility is created | After facility completion |
Key Metrics
| Metric | Q2 FY25 |
|---|---|
| Total income (H1 FY25) | ₹167 cr, +4% YoY |
| EBITDA (H1 FY25) | ₹23 cr, +38% YoY |
| EBITDA margin (H1 FY25) | 13.7%, after absorbing ~₹7 cr IPO cost; ~15% excluding IPO cost |
| PAT (H1 FY25) | ₹14 cr, +28% YoY |
| PAT margin (H1 FY25) | 8.6% |
| ROE (H1 FY25) | 14.5% |
| ROCE (H1 FY25) | 16% |
| FY25 topline guidance | ₹360–370 cr, revised from ₹400–450 cr due to capacity expansion delay |
| FY26 topline guidance | ₹650–700 cr, with capacity doubling |
| Capacity utilization | Over 90%, present plant running at 90–95% |
| Order book | ₹40–45 cr, representing 30–45 days of orders |
| Export revenue share | 3–4% of topline |
| Market share | ~4% of total market |
| Net debt | Net debt free |
| Current production capacity | 12,000 metric tons per annum |
| Post-expansion capacity | 36,000 metric tons per annum, three-fold growth |
| FY26 volume target | 24,000 metric tons, doubling present output |
| Expansion trial runs | March 2025, with full-scale operations from April 2025 |
| Radiator revenue contribution (future) | 10–15% of total revenue |
| Nanocrystalline core revenue contribution (future) | 5–6% of total revenue, after 3–4 years |
| Radiator margin vs CRGO margin | 3–4% higher than CRGO margin |
| Short-term borrowing | ₹15 cr, buyer's credit for exchange rate management |
| Trade receivables | ₹61 cr, mostly against LCs |
| Tax rate (H1 FY25) | 33% |